The 2nd Microbiome Movement - Maternal and Infant Health Summit returns as the only conference to unite large pharma, drug developers, academic KOL's and pediatric clinicians to discuss the shared challenges of helping to configure the microbiome in the first 1000 days of life to reduce risk of chronic health conditions.
With a global rise of incidences of allergies, atopic march and childhood metabolic disorders, the infant microbiome in this first 1000 days represents a key window of opportunity to create products and solutions to target and prevent the onset of these chronic health conditions.
Join leaders in the maternal-infant microbiome space as they present the latest data-driven research, an update on partnerships and insights into how future research could be conducted to benefit the field as we unlock the secrets of the infant microbiome to proactively prevent disease.
Early booking and group discounts apply, start-up and academic rates are available - see the website for details.
With a global rise of incidences of allergies, atopic march and childhood metabolic disorders, the infant microbiome in this first 1000 days represents a key window of opportunity to create products and solutions to target and prevent the onset of these chronic health conditions.
Join leaders in the maternal-infant microbiome space as they present the latest data-driven research, an update on partnerships and insights into how future research could be conducted to benefit the field as we unlock the secrets of the infant microbiome to proactively prevent disease.
Early booking and group discounts apply, start-up and academic rates are available - see the website for details.
